Evidence map›Paper›PMID 22300456›Full record

ReviewAddiction (Abingdon, England)2012

The co-occurring use and misuse of cannabis and tobacco: a review.

Arpana Agrawal, Alan J Budney, Michael T Lynskey

Abstract readReview
In one paragraph

Review in Addiction (Abingdon, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 283 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
283citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

283 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

223 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arpana AgrawalDepartment of Psychiatry, Washington University School of Medicine, 660 S. Euclid, St Louis, MO 63110, USA. arpana@wustl.edu
Alan J Budney
Michael T Lynskey

Funding

Behavioral Treatment of Adolescent Marijuana UseR01DA015186 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI BUDNEY, ALAN JEFFREY · 2002 to 2017
$7.7M
Cannabis Use, Abuse and Dependence: Exploring PhenotypesR01DA018660 · NIDA · WASHINGTON UNIVERSITY · PI LYNSKEY, MICHAEL THOMAS · 2004 to 2008
$2.6M
CANNABIS AND TOBACCO INVOLVEMENT: A TWIN STUDYR01DA023668 · NIDA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA · 2007 to 2016
$2.5M
Cannabis and Other Illicit Drug Use: A Twin StudyR01DA018267 · NIDA · WASHINGTON UNIVERSITY · PI LYNSKEY, MICHAEL THOMAS · 2005 to 2009
$2.4M
Targeting tobacco cessation during treatment for cannabis use disordersR01DA032243 · NIDA · DARTMOUTH COLLEGE · PI BUDNEY, ALAN JEFFREY · 2012 to 2015
$1.7M
Development and Efficacy Test of Computerized Treatment for Marijuana DependenceR01DA023526 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI BUDNEY, ALAN JEFFREY · 2007 to 2010
$1.6M
CHARACTERIZING THE 3-YEAR COURSE OF CANNABIS INVOLVEMENT IN NESARCR03DA025886 · NIDA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA · 2009 to 2010
$152k
NIDA NIH HHS DA15186NIDA NIH HHS DA18267NIDA NIH HHS DA18660NIDA NIH HHS DA23526NIDA NIH HHS DA23668NIDA NIH HHS R01 DA015186NIDA NIH HHS R01 DA018267NIDA NIH HHS R01 DA018660NIDA NIH HHS R01 DA023526NIDA NIH HHS R01 DA023668NIDA NIH HHS R01 DA032243NIDA NIH HHS R03 DA025886
6 · The paper itself

Abstract

aimsCannabis and tobacco use and misuse frequently co-occur. This review examines the epidemiological evidence supporting the life-time co-occurrence of cannabis and tobacco use and outlines the mechanisms that link these drugs to each other. Mechanisms include (i) shared genetic factors; (ii) shared environmental influences, including (iii) route of administration (via smoking), (iv) co-administration and (v) models of co-use. We also discuss respiratory harms associated with co-use of cannabis and tobacco, overlapping withdrawal syndromes and outline treatment implications for co-occurring use.

methodsSelective review of published studies.

resultsBoth cannabis and tobacco use and misuse are influenced by genetic factors, and a proportion of these genetic factors influence both cannabis and tobacco use and misuse. Environmental factors such as availability play an important role, with economic models suggesting a complementary relationship where increases in price of one drug decrease the use of the other. Route of administration and smoking cues may contribute to their sustained use. Similar withdrawal syndromes, with many symptoms in common, may have important treatment implications. Emerging evidence suggests that dual abstinence may predict better cessation outcomes, yet empirically researched treatments tailored for co-occurring use are lacking.

conclusionsThere is accumulating evidence that some mechanisms linking cannabis and tobacco use are distinct from those contributing to co-occurring use of drugs in general. There is an urgent need for research to identify the underlying mechanisms and harness their potential etiological implications to tailor treatment options for this serious public health challenge.

Indexed as

AdolescentAdultAgedCommerceFemaleForecastingHumansMaleMarijuana AbuseMiddle AgedPeer GroupSubstance Withdrawal SyndromeTobacco Use DisorderYoung Adult

Identifiers

PMID22300456
PMCPMC3397803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.